Selenium in the prevention and subsidiary therapy of cancer of soft tissues
Authors:
Andrea Raganová; Andrea Gažová; Igor Tomo; Viera Kristová
Published in the journal:
Čes. slov. Farm., 2018; 67, 66-70
Category:
Review Articles
Summary
Selenium as an antioxidant has attracted attention because of its anticancer activity. This review presents a view on selenium and its compounds exerting influence against cancer in the soft tissues. The results reveal a significant strong association between a low selenium level in blood and a cancer risk. Seleno-supplementation is important in the prevention of metastatic cancer. These results help to elucidate the anticancer effect of selenium providing further evidence to exploit novel anticancer agents targeting selenium-containing organic compounds.
Key words:
selenium • cancer prevention • cancer treatment • soft tissues
Zdroje
1. Vinceti M., Filippini T., del Giovane C., Dennert G., Zwahlen M., Brinkman M., Zeegers M.P., Horneber M., et al. Selenium for preventing cancer. Cochrane Database Syst. Rev. 2018; 29(1): CD005195. doi: 10.1002/14651858.CD005195.pub4
2. Klein E. A., Thompson I. M. Chemoprevention of prostate cancer: an updated view.World J Urol. World J. Urol. 2012; 2012;30, 189–194.
3. Loeb S., et al. Do environmental factors modify the genetic risk of prostate cancer? Cancer epidemiology biomarkers and prevention. 2015; 24, 213–220.
4. Kenfield S. A., Blarigan E. V., et al.: Selenium supplementation and prostate cancer mortality. J. Natl. Cancer Inst. 2015; 107, 360–367.
5. Hughes D. J., Duarte-Salles T., Hyvsier S., Trichopoulou A., et al. Cancer risk and vitamines. Am. J. Clin. Nutr. 2016; 104, 406–414.
6. Kasaikina M. V., Turanov A. A., Avanesov A., Schweizer U., et al. Contrasting roles of dietary selenium and selenoproteins in chemically induced hepatocarcinogenesis. Carcinogenesis. 2013; 34, 1089–1095.
7. Fan T., Zheng W., Xiaovan F., Xialing L., et al. Strategy to enhance the therapeutic effect of doxorubicin in human hepatocellular carcinome by selenocystine, a synergistic agent that regulates the ROS – mediated signaling. Oncotarget. 2014; 5, 2–4.
8. Lener H., Gupta S., Scott R. J., et al. Can selenium levels act as a market of colorectal cancer risk? BMC Cancer. 2013; 13, 1204–1208.
9. Yang G., Hui L., Kaiyuan H., Yali C., et al. Selenite – induced autofagy antagonizes appoptosis in colorectal cancer cell in vitro and in vivo. Oncology report. 2016; 35, 1255– 1264.
10. Chen J. M., Pabhu K. S., Das A., Mastro A. M. Dietary selenium suplementation modifies brest tumor growth and metastasis. Int. J. Cancer. 2013; 133, 2054–2064.
11. Brozmanová J. Selén a rakovina: od prevencie k liečbe. Klin. Onkol. 2011; 24, 171–179.
12. Kulak M. V., Cyr A. R., Woodfield G. W., Boqachek M., et al. Transcriptional regulation of the GP × 1 gene by TFAP2C and aberrant CPG methylation in human breast cancer. Onkogene 2013; 32, 4043–4051.
13. Huebner J., Muendstedt K., Prott F. J., Micke O., et al. Online survey of Patients with brest cancer on Complementary and alternative medicine. Breast care 2014; 9, 60–63.
14. Wanq L., Wanq J., Liu X., Liu Q., Zhang G., Lianq L., et al. Association between selenium intake and the risk of pancreatic cancer: a meta-analysis of abservational studies. Bioscience reports 2016; 36, 123–126.
15. Chen J. M., Jiang W., Shao L., Zhong D., Wu Y., Cai J. Association between intake of antioxidants and pancreatic cacer risk: a meta – analyses. Int. J. Food Sci. Nutr. 2016; 67, 744–753.
16. Han X. S., Li J., Brasky T. M., Xun P., Stevens J., et al. Antioxidant intake and pancreatic cancer risk the vitamins and lifestyle study. Cancer 2013; 119, 1314–1320.
17. Lener M. R., Scott R. J., Wiechowska-Kozlowska A., et al. Serum concentrations of selenium and cooper in patients diagnoses with pancreatic cancer. Cancer research and treatment 2016; 48, 1056–1064.
18. Tan X., Wsn Y. P., Li M. X., Chen S. H., et al. Downregulation of selenium-binding protein 1 associated with poor prognoses in lung squamous cell carcinome. World J. Surg. Oncol. 2016; 14, 1112–1119.
19. Oh I. J., Kim H. E., Song S. Y., Na K. J., et al.: Diagnostic value of serum glutatione peroxidase 3 levels in patients with lung cancer. Thoracic cancer 2014; 5, 425–430.
20. ShimS. H., Yoom M. J., Kim M., et al.: Enhanced lung cancer cell killing by the combination of selenium and ionizing radiation. Oncol. Rep. 2007; 17, 209–216.
21. Wrobel J. K., Seelbach M. J., Chen L., Power R. F., Toborek M. Supplementation with selenium – enriched yeast attenuates brain metastatic growth. Nutr. Cancer 2013; 65, 563–570.
22. Wrobel J. K., Wolff G., Xiao R., et al. Dietary selenium supplementation modulates growth of brain metastatic tumors and changes the expression of adhesion molecular in brain microvessels. Biological trace element research 2016; 172, 395–407.
Štítky
Pharmacy Clinical pharmacologyČlánok vyšiel v časopise
Czech and Slovak Pharmacy
2018 Číslo 2
Najčítanejšie v tomto čísle
- On the content of the National part of the Czech Pharmacopoeia 2017
- Superdisintegrants used in pharmaceutical technology
- Microbiome in connection with metabolic syndrome and the therapeutic potential of its influencing
- Melatonin as a structural template in the development of novel drugs for neurodegenerative disorders